期刊文献+

靶向VEGF基因的siRNA联合树突状细胞介导的CTL对MCF-7细胞作用的研究

Effects of siRNA directed against VEGF gene and CTL mediated by DCs loaded tumor antigen on MCF-7 Breast Cancer cells
下载PDF
导出
摘要 目的探讨靶向血管内皮细胞生长因子(VEGF)基因的小干扰RNA(siRNA)联合负载肿瘤抗原的树突状细胞(DC)致敏的细胞毒性T淋巴细胞(CTL)的联合抗瘤作用。方法体外应用靶向VEGF基因最佳转染浓度(100nmol/L,增加浓度不再提高沉默作用)的siRNA联合负载人乳腺癌细胞(MCF-7细胞)抗原的DC介导的CTL(siRNAVEGF+CTL组)共同作用于MCF-7细胞,同时设立空白对照组和空白+CTL组(只加无血清无抗生素培养基);脂质体组和脂质体+CTL组(只加LipofectamineTM2000);siRNAVEGF-组(100nmol/LsiRNA);siRNASCR组和siR-NASCR+CTL组(100nmol/LsiRNASCR),每组做6个平行孔,四甲基偶氮唑蓝(MTT)法检测siRNAVEGF+CTL组和各对照组肿瘤杀伤活性(n=6),Hoechst33258核染色观察细胞的凋亡(n=3)。结果siRNAVEGF+CTL组、siR-NAVEGF-组siRNASCRCTL组肿瘤杀伤活性分别为99.37%,51.17%和43.94%,siRNAVEGF+CTL组与对照组比较可明显杀伤肿瘤细胞,瘤细胞几乎完全溶解,Hoechst33258显示细胞核呈明显的细胞凋亡改变。结论体外实验显示靶向VEGF的siRNA联合负载肿瘤抗原DC致敏的CTL能有效抑制乳腺癌MCF-7细胞的生长,二者的联合应用抗瘤效果显著。 Objective To investigate the effects of siRNA directed against VEGF gene and cytotoxic T lymphocyte(CTL)mediated by DCs loaded tumor-specific antigen on MCF-7 Breast Cancer cells.Medhods In vitro small interfering RNAs(siRNAs)directed against VEGF gene were designed and transfected into MCF-7 breast cancer cells at the optimal concentration(100 nmol/L)using cationic liposome Lipofectamine^TM 2000,then combinted CTL mediated by DCs(siRNAVEGF+CTL group)were used to against MCF-7 breast cancer cells.At the same time,the following groups were designed:blank control group and blank+CTL group(only with serum-free medium without antibiotics);liposome group and liposome+CTL group(added Lipofectamine^TM2000 only);siRNAVEGF-group and siRNAVEGF+CTL group(100 nmol/L siRNA);siRNASCR and siRNASCR+CTL group(100 nmol/L siRNASCR).Tumor killing effects in both siRNAVEGF+CTL group and control groups were measured by MTT(n=6)assay and Hoechst33258(n=3).Results The tumor killing effects in siRNAVEGF+CTL,siRNAVEGF and siRNASCR CTL groups were 99.37%,51.17% and 43.94%,respectively,obviously increased in siRNAVEGF+CTL group compared with the control groups(P〈0.01).The tumor cells were almost completely lysis and Hoechst33258 showed obviously apoptosis in nucleis in siRNAVEGF+CTL group.Conclusion The experiment demonstrated that siRNA directed against VEGF gene combined CTL mediated by DCs could inhibit the growth of MCF-7 cells,and with a more significant antitumor effect by the combined application.
出处 《中国输血杂志》 CAS CSCD 北大核心 2010年第2期92-96,共5页 Chinese Journal of Blood Transfusion
基金 青岛市科技局科技计划项目(编号:07-2-1-7-nsh)
关键词 RNA干扰 VEGF 树突状细胞 MCF-7细孢 siRNA VEGF Dendritic cells MCF-7 cells
  • 相关文献

参考文献19

  • 1Parkin DM, Feynadez LM. Use of sialics to assess the global burden of breast cancer. Breast J, 2006, 12 (S):70-80.
  • 2Byme GL, McDowell G,Agarawal R, el al. Serum vascular endothelial growth factor in breast cancer. Anticancer Res,2007 , 27(5B) :3481-3487.
  • 3李捷,宋三泰,江泽飞,刘晓晴,颜玲娣.血管内皮生长因子及微血管密度在乳腺癌中的表达及意义[J].中华肿瘤杂志,2003,25(2):145-147. 被引量:36
  • 4朱学军,曹雪涛,于益芝,陈国友,万涛,马施华,唐华,章卫平.人外周血树突状细胞的体外扩增及鉴定[J].中国肿瘤生物治疗杂志,1997,4(4):302-306. 被引量:91
  • 5Kugler A, Stuhler G, Walden P, et al. Regression of human metastatic renal cell carcinoma after vaccinalion with tumor ceil dendritic cell hybrids. Nat Med, 2000, 6(3):332-336.
  • 6Brossarl P. Wirths S, Brugger W, et al. Dendritic cells in cancer vaccines. Exp Hematol, 2001, 29(11):1247-1255.
  • 7Gabrilovich DI, Chen HL, Girgis KR, el al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med, 1996, 2 (11) : 1096-1103.
  • 8李霞,徐文华,曹明智,侯琳,徐宏伟,杜卫,葛银林.下调VECF基因表达对乳腺癌细胞MCF-7的增殖抑制作用[J].医学分子生物学杂志,2005,2(4):262-265. 被引量:6
  • 9Pilon-Thamas S, Verhaegen M, Kuhn L, et al. Induction of antitumor immunity by vaccination with dendritic cells pulsed with anti-CD44 lgG opsonized tumor cells. Cancer Immunol Immunother. 2006, 55 ( 10 ) : 1238-1246.
  • 10Ojima T, lwahashi M, Nakamura M, et al. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic' cells expressing tumor-associated antigen, Int J Oncol,2006, 28(4) :947-953.

二级参考文献42

  • 1杨光,曹国军,李洁,纪晓光,赵艳红,王京燕,柳川,范明,沈倍奋,邵宁生.siRNA抑制SARS冠状病毒感染Vero E6细胞[J].医学分子生物学杂志,2004,1(5):270-273. 被引量:9
  • 2李霞,徐文华,曹明智,侯琳,徐宏伟,杜卫,葛银林.下调VECF基因表达对乳腺癌细胞MCF-7的增殖抑制作用[J].医学分子生物学杂志,2005,2(4):262-265. 被引量:6
  • 3张淑华,葛银林,罗达亚,田润华.小干扰RNA靶向VEGF基因体内外抑制乳腺癌细胞MCF-7的增殖[J].中国生物化学与分子生物学报,2007,23(1):68-73. 被引量:12
  • 4Tomoda M, Maehara Y, Kakeji Y, et al. Intratumoral neovascularization and growth pattern in early gastric carcinoma [J ]. Cancer, 1999 ,$5( 11 ) : 2340-2346
  • 5Commeren D L, Van Soest P L, Karimi K, et al. Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells [J]. Immunology,2003,110(2) : 188-196
  • 6Ohm J E, Carbone D P. VEGF as a mediator of tumor-associated immunodeficiency[J]. Immunol Res, 2001,23(2-3) :263-272
  • 7Laxmanan S, Robertson S W, Wang E, et al. Vascular endothelial cell growth factor impairs the functional ability of dendritic cells through Id pathways [J]. Biochem Biophys Res Commun, 2005, 334 (1) :193-198
  • 8Almand B, Resser J R, Lindman B, et al. Clinical significance of defective dendritic cell differentiation in cancer [ J]. Clin Cancer Res,2000, 6(5) : 1755-1766
  • 9Orsini E, Guarini A, Chiaretti S, et al. The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response [J]. Cancer Res, 2003,63(15) :4497-4506
  • 10Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics [ J]. Nat Rev Drug Discov, 2004,3 (4) :318-329

共引文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部